Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1838 (LINC01838) is a member of the long non-coding RNA (lncRNA) family, specifically categorized as a long intergenic non-coding RNA (lincRNA). lincRNAs are autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes. While the family of lincRNAs is known to participate in regulation of gene expression, chromatin remodeling, and transcriptional control, little specific functional or disease-related information is established for LINC01838 itself. There is no evidence to classify LINC01838 as a direct therapeutic target (such as a receptor, enzyme, or transporter), nor are there known drug interactions, established biomarker roles, or disease associations in current sources[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1838 (LINC01838).